We came across a bullish thesis on AbbVie Inc. (ABBV) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc. (ABBV)’s share was trading at $198.47 as of May 2nd. ABBV’s trailing and forward P/E were 84.82 and 16.34 respectively according to Yahoo Finance.
A clinical researcher in a lab examining a new biopharmaceutical product.
AbbVie (ABBV) delivered a strong Q1 2025 performance that exceeded expectations and was met with a sharp rise...
